Prospective and GCP testing of tumors for important somatic variants in cancer is becoming more commonplace in clinics and especially in clinical trials. Currently, there is a lack of generally available, reliable, and perpetual genomic reference material that can be used across a wide range of genomic testing methods for assessing the potential accuracy of a given test.
The SEQC2 consortium, led by the FDA, was chartered with examining best practices in DNA testing (especially detection of germline vs. somatic variation) across a wide spectrum of methods. Working Group #2 of the SEQC2 consortium was challenged with examining the reproducibility, sensitivity and accuracy of current (or in-development) commercially available tumor panels for both solid tumor testing and for liquid biopsies. We quickly identified that to perform such an examination, we needed to construct ground truth of additional DNA reference material, including a material that would have a sufficient magnitude of variants to conduct statistically powerful and meaningful performance assessments.
Complete the form below to access this scientific poster
Related Insights
Reproducibility Challenges in an era of Massive Data
Presented at the MCBIOS & MAQC 2021 Joint Conference
A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency
Presented at the MCBIOS & MAQC 2021 Joint Conference
Unexpected Impacts to Library Complexity After DNA and RNA Library Preparation in Illumina Next Generation Sequencing
Presented at the MCBIOS & MAQC 2021 Joint Conference
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy
Gene expression and analysis for detection of 38 Immune Landscape Signatures
Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials
Genomic technologies that empower and enhance immuno-oncology trials
Laboratory Solutions for Hepatitis B (HBV) Clinical Trials
Insight brief by Joseph Sebastian, Ph.D., Scientific Advisor, Infectious & Liver Diseases
Enabling blood sample prep for single cell sequencing in clinical research
The Role of Genomics in Clinical Trials with Patrick Hurban
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Evaluating and Implementing SARS-CoV-2 PCR Tests for Diagnostic and Clinical Trial Use
AAPS 2020 COVID-19 Workshop: Current Pharmaceutical Developments for Cures and Prevention
